A Matched Case‐Control Study to Evaluate Predicted Drug Exposures and Neutropenia during Valganciclovir Prophylaxis in Pediatric Solid Organ Transplant Recipients

Documenti analoghi

• NUDT15 Genetic Polymorphism as a Risk Factor for Early Neutropenia During Valganciclovir Prophylaxis in Lung Transplant Patients
  di: Yurie Katsube, et al.
  Pubblicazione: (2025)
• Alternative Pneumocystis Pneumonia Prophylaxis in Solid Organ Transplants
  di: Kevin D. He, et al.
  Pubblicazione: (2024)
• Bacteremia in Pediatric Solid Organ Transplant Recipients within 1 Year of Transplant
  di: Mario M. Landa, et al.
  Pubblicazione: (2025)
• Utilization of a CMV T Cell Immunity Assay to Guide Secondary Prophylaxis in Solid Organ Transplant Recipients
  di: Christina Doligalski, et al.
  Pubblicazione: (2026)
• International Survey on Antibiotic Prophylaxis Approaches for Solid Organ Transplant Recipients and Donors Colonized With Multidrug‐Resistant Organisms
  di: Julia Bini Viotti, et al.
  Pubblicazione: (2025)